Delivery Order SPE2DB22D3004-SPE2DB23FRG77
Award Date
9/12/23
Potential Completion Date
10/3/23
Potential Value
$4.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $906.36 firm fixed price delivery order by the Defense Logistics Agency to supply RHOPHYLAC 300 MCG/2 ML SYRINGES. Performance will take place in Conshohocken, Pennsylvania over a period of approximately three weeks concluding on September 27, 2023. The Defense Logistics Agency utilizes contracts such as this to efficiently procure necessary medical supplies and equipment in support of the...
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product. The $1,850.00 firm fixed price contract has a completion date of March 25, 2024. AmerisourceBergen Drug Corp is a prime contractor that supplies a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense,...
Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $453,170 delivery order by the Defense Logistics Agency to supply RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML pharmaceutical products. The firm fixed price order is for product delivery from the contractor's facility in Conshohocken, Pennsylvania and has a period of performance extending from August 29, 2023 through September 20, 2023. No set aside designation or subcontracting details were provided....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,309.06 firm fixed price delivery order is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product. The order has an ultimate completion date of April 23, 2024.
Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $906.36 firm fixed price delivery order by the Defense Logistics Agency to supply 300 mcg/2ml syringes of RHOPHYLAC. The delivery order is placed against an indefinite-delivery/indefinite-quantity contract vehicle to support the agency's pharmaceutical procurement programs. Performance will take place in Conshohocken, Pennsylvania over a three week period concluding in early August. No...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. The contract is a Delivery Order valued at $1,387.50 with a performance period ending on August 14, 2024. It is a Firm Fixed Price contract, without any set-aside designation. AmerisourceBergen, through its Corporate Office division, will deliver these critical medical supplies to support military...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $2,775.00 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The contract is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML and has a performance period through March 20, 2024. This award is issued under Amerisourcebergen Drug Corp's single award indefinite delivery contract with DLA, valued at up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a medical product. The contract, valued at $1,380.52, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). The contract has an ultimate completion date of August 14, 2024, and is structured as a Firm Fixed Price Delivery Order. Amerisourcebergen is a well-established federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,836.04 firm fixed price contract is for the supply of RHOPHYLAC, a 300 mcg/2 mL syringe medication, with an ultimate completion date of October 15, 2024. The award does not utilize a set-aside designation. AmerisourceBergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, collectively valued up to...
This federal contract award is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,295.05 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 26, 2024, with a completion date of August 16, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...